Heartflow (HTFL) Cash from Financing Activities (2024 - 2025)

Heartflow (HTFL) posted quarterly Cash from Financing Activities of -$50000.0 for Q4 2025, down 105.88% year-over-year from $851000.0 in Q4 2024, and down 100.02% quarter-over-quarter from $214.9 million in Q3 2025.

Heartflow (HTFL) Cash from Financing Activities (2024 - 2025) Analysis & Trends

Heartflow's Cash from Financing Activities history runs 2 years deep, the most recent figure standing at -$50000.0 for Q4 2025.

  • In Q4 2025, Cash from Financing Activities fell 105.88% year-over-year to -$50000.0; the TTM figure through Dec 2025 stood at $216.7 million (changed N/A YoY), while the FY2025 annual figure was $286.0 million, up 12686.9% from the prior year.
  • Cash from Financing Activities for Q4 2025 stood at -$50000.0, down from $214.9 million in the prior quarter.
  • The five-year high for Cash from Financing Activities was $214.9 million in Q3 2025, with the low at -$50000.0 in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Veeva Systems 39.72 Bn 32.40 Bn 662.02 Mn -262.53 Mn
2 BrightSpring Health Services 12.19 Bn 11.64 Bn 492.75 Mn -354.13 Mn
3 Healthequity 8.79 Bn 8.52 Bn 256.31 Mn -137.18 Mn
4 10x Genomics 7.31 Bn 6.76 Bn 112.50 Mn 3.02 Mn
5 Hinge Health 7.10 Bn 6.71 Bn 183.95 Mn -30.48 Mn
6 MiniMed 5.66 Bn 5.36 Bn 480.00 Mn 512.00 Mn
7 Waystar Holding 4.76 Bn 4.56 Bn 221.99 Mn -7.10 Mn
8 Doximity 4.46 Bn 3.77 Bn 132.93 Mn -100.55 Mn
9 Heartflow 3.66 Bn 3.28 Bn 53.19 Mn -
10 Privia Health 2.78 Bn 2.42 Bn - 3.04 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 -50,000.00
Dec 31, 2025 -50,000.00
Sep 30, 2025 214.94 Mn
Sep 30, 2025 214.94 Mn
Dec 31, 2024 851,000.00
Dec 31, 2024 851,000.00
Sep 30, 2024 983,000.00
Sep 30, 2024 983,000.00